DOI QR코드

DOI QR Code

Castleman Disease Presenting with Jaundice: A Case with the Multicentric Hyaline Vascular Variant

  • Park, Jun-Bean (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Hwang, Jin-Hyeok (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Hae-Ryoung (Department of Pathology, Seoul National University Bundang Hospital) ;
  • Choe, Hyung-Sim (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Kim, Yu-Kyeong (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
  • Kim, Hong-Bin (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Bang, Soo-Mee (Departments of Internal Medicine, Seoul National University Bundang Hospital)
  • Published : 20070600

Abstract

Castleman disease (CD) is a rare lymphoproliferative disorder of unknown etiology with different clinical manifestations. A previous healthy 50 year-old man was hospitalized for right upper quadrant (RUQ) abdominal pain. He had jaundice and a 1 cm-sized lymph node in the right supraclavicular area. Pancreas and biliary computed tomography (CT) showed masses at the right renal hilum and peripancreatic areas. Positron emission tomography (PET) showed widespread systemic lymphadenopathy. Excisional biopsy of the right supraclavicular node revealed a hyaline vascular variant of CD. Corticosteroid therapy was started and the extent of disease decreased. We here report a case of multicentric CD, the hyaline vascular variant, presenting with jaundice, diagnosed by excisional biopsy and successfully treated with corticosteroids.

Keywords

References

  1. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic feature of Castleman disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985 https://doi.org/10.1200/JCO.1985.3.9.1202
  2. Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335-344, 2000 https://doi.org/10.1006/viro.2000.0196
  3. Menke DM, Chadbum A, Cesarman E, Green E, Berenson J, Said J, Tiemann M, Parwaresch R, Thome SD. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. Am J Clin Path 117:268-275, 2002 https://doi.org/10.1309/7243-AV50-KJ28-V6J9
  4. Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103:1632-1634, 2004 https://doi.org/10.1182/blood-2003-05-1721
  5. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129:3-17, 2005 https://doi.org/10.1111/j.1365-2141.2004.05311.x
  6. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367, 1989
  7. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254, 1995
  8. Reddy MP, Graham MM. FDG positron emission tomographic imaging of thoracic Castleman disease. Clin Nucl Med 28:325-326, 2003 https://doi.org/10.1097/00003072-200304000-00015
  9. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657-662, 1998 https://doi.org/10.7326/0003-4819-128-8-199804150-00010
  10. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995
  11. Przkora R, Bruns C, Zulke C, Heinkelein J, Rummele P, Schalhorn A, Jauch KW. Castleman disease causing obstructive jaundice. J Hepatol 38:548-549, 2003 https://doi.org/10.1016/S0168-8278(02)00437-3
  12. Al-Salamah SM, Khan IA, Khalid K, Al-Shakweer WA. Castleman disease presenting as obstructive jaundice. Saudi Med J 26:111-113, 2005